Caribou Biosciences, Inc. Increase (Decrease) in Deferred Liabilities
Caribou Biosciences, Inc. (CRBU) reported Increase (Decrease) in Deferred Liabilities of -$548.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredLiabilities · last filed 2026-03-05
- Caribou Biosciences, Inc. increase (decrease) in deferred liabilities for the quarter ending 2020-12-31 was $57.00K.
- Caribou Biosciences, Inc. increase (decrease) in deferred liabilities for the quarter ending 2020-09-30 was -$213.00K.
- Caribou Biosciences, Inc. increase (decrease) in deferred liabilities for fiscal 2025 was -$548.00K.
- Caribou Biosciences, Inc. increase (decrease) in deferred liabilities for fiscal 2024 was -$10.00K, a 105.65% decline from fiscal 2023.
- Caribou Biosciences, Inc. increase (decrease) in deferred liabilities for fiscal 2023 was $177.00K.
- Caribou Biosciences, Inc. increase (decrease) in deferred liabilities for fiscal 2022 was -$95.00K, a 129.60% decline from fiscal 2021.
| Period end | Increase (Decrease) in Deferred Liabilities 3 month | Increase (Decrease) in Deferred Liabilities 6 month | Increase (Decrease) in Deferred Liabilities 9 month | Increase (Decrease) in Deferred Liabilities 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$548.00K 10-K · filed 2026-03-05 | |||
| 2024-12-31 | -$10.00K 10-K · filed 2026-03-05 | |||
| 2023-12-31 | $177.00K 10-K · filed 2025-03-10 | |||
| 2022-12-31 | -$95.00K 10-K · filed 2024-03-11 | |||
| 2021-12-31 | $321.00K 10-K · filed 2023-03-09 | |||
| 2021-06-30 | $0.00 10-Q · filed 2021-09-02 | |||
| 2020-12-31 | $57.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | -$156.00K derived: sum of 2 quarters · filed 2022-03-21 | -$495.00K 10-K · filed 2022-03-21 | |
| 2020-09-30 | -$213.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$552.00K 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | -$339.00K 10-Q · filed 2021-09-02 | |||
| 2019-12-31 | -$7.11M 10-K · filed 2022-03-21 |